Litcius/Paper detail

Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions

Tania Blanco-Martín, Isaac Alonso-García, Lucía González-Pinto, Michelle Outeda-García, Paula Guijarro-Sánchez, Inmaculada López-Hernández, Marı́a Pérez-Vázquez, Belén Aracil, Lorena López‐Cerero, Pablo A. Fraile-Ribot, Antonio Oliver, Juan Carlos Vázquez-Ucha, Alejandro Beceiro, Germán Bou, Jorge Arca-Suárez

2024International Journal of Antimicrobial Agents31 citationsDOIOpen Access PDF

Topics & Concepts

Escherichia coliMicrobiologyBiologyEnterobacteriaceaeCephalosporinAntibioticsGeneGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICU
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions | Litcius